Main pageFrance

Welcome to PinkRibbon France

You’re not alone. This page shares key facts about common female cancers in France, survival stats, health initiatives, and trusted support organisations. Our mission is to ensure every woman has access to awareness, early detection, and compassionate care.

Cancer statistics
& survival rates

• Breast Cancer
Most common cancer in French women.
National screening contributes to relatively high early detection rates.
Survival rates over 85%, improving with personalized therapies and rapid access to care.
• Cervical Cancer
Declining due to HPV vaccination and organized screening.
Higher incidence persists in under-screened populations (e.g., immigrant women).
• Ovarian Cancer
Typically diagnosed late due to vague symptoms.
Survival: ~90% early stage; ~30–50% in advanced stages.
National focus on rapid diagnostic pathways and genetic testing (BRCA).
• Endometrial (Uterine) Cancer
Rising among postmenopausal women; linked to obesity and lifestyle factors.
Detected early in most cases; prognosis generally good with early intervention.
Systemic Challenges
• Geographic Disparities: Access to specialized care and timely diagnostics varies across regions, with urban areas better served.
• Screening Participation: Despite free programs, participation rates in some areas remain below target (e.g., <60% cervical screening).
• Cultural and Language Barriers: Immigrant populations may face challenges in navigating the healthcare system or understanding prevention.
• Healthcare Pressure: Oncologist shortages and hospital strain, especially in rural areas, impact timely treatment.
National Highlights
• Institut Curie leads Europe-wide trials in personalized breast cancer treatment.
• Gustave Roussy pioneers AI in gynecological cancer diagnostics.
• IMAGYN and RoseUp foster survivor communities and push for equity in FGRC awareness.
• HPV Vaccine Access expanded in 2023 with school-based programs targeting ages 11–14.

Learn more

Recent research
& Initiatives

  • Recent Research

    • Breast Cancer: French studies continue to explore genetic markers (e.g., BRCA mutations) and the impact of personalized treatment strategies. Survival remains high—around 88% 5-year survival—with disparities linked to age, geography, and socio-economic status.
    • Cervical Cancer: Ongoing work emphasizes HPV vaccination rollout and follow-up screening participation. National data show declines in incidence due to effective Pap smear programs.
    • Ovarian Cancer: Research focuses on earlier detection methods, such as CA125 biomarker advancements and AI imaging analysis.
    • Endometrial Cancer: Rising incidence has prompted research into risk mitigation, especially among obese and diabetic populations.

    Learn more

Support organizations

  • Support Organisations

    • La Ligue contre le Cancer: Offers nationwide support, prevention campaigns, and patient advocacy.
    • Europa Donna France: Dedicated to breast cancer awareness, patient rights, and early screening.
    • Association IMAGYN: Supports gynecological cancer patients (including ovarian, uterine, cervical), offering forums and advocacy.
    • RoseUp Association: Provides education, community support, and resources for women with all cancer types.
    • ARC Foundation (Fondation ARC): Funds cancer research and awareness campaigns, with a focus on prevention and early detection.

Accessing cancer screening and treatment

Where to get screened

These services are part of the national screening program “Prolamvano” (meaning “I Prevent”)

Learn more

  • Where to Get Screened
    • Screenings are provided through public health services (Assurance Maladie) and local health centers.
    • National screening programs exist for breast (every 2 years for women 50–74) and cervical cancer (starting at age 25).
    • Ovarian and endometrial screenings are not routine; assessments based on risk factors or symptoms.

    **Appointment Needed?
    Yes. Appointments are typically required through general practitioners or gynecologists.**

    **What to Bring:
    • Carte Vitale (health insurance card)
    • National ID
    • Medical history or test results if relevant**

    **Hotline Numbers:
    • Cancer Info Service (La Ligue): 0 805 123 124 (free, anonymous)
    • Assurance Maladie General Info Line: 36 46**

    Learn more

Support is nearby

Hotline numbers

0 805 123 124
Hours: Monday–Friday, 9 AM–7 PM

Where to get treatment

Financial support

  • • Government Programs
    ALD status grants 100% reimbursement on approved treatment.
    CAF (Caisse d’Allocations Familiales) may provide financial aid for caregivers or loss of income.
    • Additional Support
    Organizations like La Ligue contre le Cancer offer grants for housing, travel, and temporary work leave.
    Mutuelle (private insurance) often supplements out-of-pocket costs.
    Patients should consult social workers at treatment centers for personalized financial guidance.

Need someone to talk to, anytime?

Our AI Chat is trained to support you with:

  • Gentle answers to medical questions (in clear, human language)
  • Answer health questions in simple, caring language
  • Help you find the right info on our website
  • Suggest clinics, support groups, and next steps
  • Be a listening ear when you need one
Support 24\7

Start using our chat right now

AI Chat